HypoglycemiaHyperglycemiaBlood GlucoseInsulin ComaDiabetes Mellitus, Type 1InsulinHypoglycemic AgentsDiabetes Mellitus, Type 2Hemoglobin A, GlycosylatedDiabetic KetoacidosisInsulin, Long-ActingDiabetes MellitusInsulin Infusion SystemsDiabetes Mellitus, ExperimentalBlood Glucose Self-MonitoringInsulin, Regular, PorkInsulin LisproGliclazideGlucagonHyperinsulinismIslets of LangerhansInfusions, SubcutaneousGlucoseCongenital HyperinsulinismSulfonylurea CompoundsInsulin, IsophaneInsulin AntibodiesGlucose Clamp TechniqueCritical IllnessEpinephrineAwarenessDiabetes ComplicationsRisk FactorsPancreatic PolypeptideComaMetforminIslets of Langerhans TransplantationSeverity of Illness IndexDiabetic AngiopathiesRetrospective StudiesC-PeptideTreatment OutcomeTime FactorsClinical AlarmsGlucose Tolerance TestDrug Administration ScheduleInjections, SubcutaneousBrain DiseasesCognitionSeizuresStreptozocinIncidenceVentromedial Hypothalamic NucleusRats, Sprague-DawleyBrainFastingNesidioblastosisGluconeogenesisInsulinomaFollow-Up StudiesHydrocortisoneGermanyProspective StudiesDiabetes, GestationalInsulin-Secreting CellsPregnancy in DiabeticsPancreas, ArtificialPostprandial PeriodGlipizideIntervention StudiesCognition DisordersInsulin ResistanceNorepinephrineCardiovascular DiseasesHomeostasisGlucokinaseFatty Acids, NonesterifiedGlucagon-Like Peptide 1Case-Control StudiesInsulin Aspart3-Hydroxybutyric AcidDiazoxideMonitoring, AmbulatoryDiabetic NeuropathiesDipeptidyl-Peptidase IV InhibitorsPancreasReference ValuesLiver